市場調查報告書

Atorvastatin API的全球市場

Global Atorvastatin API Market Research Report Forecast to 2023

出版商 Market Research Future 商品編碼 908212
出版日期 內容資訊 英文 85 Pages
訂單完成後即時交付
價格
Back to Top
Atorvastatin API的全球市場 Global Atorvastatin API Market Research Report Forecast to 2023
出版日期: 2019年07月31日內容資訊: 英文 85 Pages
簡介

本報告提供全球Atorvastatin API市場的相關調查,市場機會,成長及阻礙因素,各用途、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 摘要整理

  • 市場魅力分析
    • 各用途
    • 各地區

第2章 市場介紹

  • 定義
  • 調查範圍
  • 市場結構

第3章 調查方法

  • 調查方法
  • 一次調查
  • 二次調查
  • 市場規模的估計
  • 預測模式
  • 假設的清單

第4章 市場動態

  • 簡介
  • 成長要素
  • 阻礙因素
  • 市場機會

第5章 市場要素分析

  • 價值鏈分析
    • 研究開發
    • 製造
    • 流通及銷售
    • 銷售後的監視
  • 波特的五力分析
    • 新加入廠商的威脅
    • 產業內的競爭
    • 替代品的威脅
    • 供應商談判力
    • 買主談判力
  • 法規方案
  • 開發平台分析
    • 簡介
    • Atorvastatin鈣片,40 mg
    • Atorvastatin鈣10 mg
    • Atorvastatin
  • 價格的發展

第6章 全球市場:各用途

  • 簡介
  • 高膽固醇症
  • 高甘油三酯血症
  • 血脂異常症
  • 其他

第7章 全球市場:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 南美
  • 歐洲
    • 法國
    • 英國
    • 西班牙
    • 德國
    • 義大利
    • 東歐
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他
  • 中東、非洲地區
    • 中東
    • 非洲

第8章 競爭情形

  • 競爭情形
    • 簡介

第9章 企業簡介

  • Teva Pharmaceutical Industries Ltd
  • Jubilant Life Sciences Ltd
  • Dr. Reddy's Laboratories Ltd
  • Sun Pharmaceutical Industries Ltd
  • Ind-Swift Labs Ltd
  • Morepen Laboratories Ltd
  • Zhejiang Hisun Pharmaceutical Co Ltd
  • Anuh Pharma Ltd
  • Centrient Pharmaceuticals
  • Cadila Pharmaceuticals

第10章 結論

目錄

Global Atorvastatin API Market: Information by Application (Hypercholesterolemia, Hypertriglyceridemia, Dyslipidemia and others) and Region (North America, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2023

Market analysis

The Global Atorvastatin API Market has been principally profited by the mounting implementation of atorvastatin in handling cardiovascular diseases. The rise of dyslipidemia in China delivers openings for growth in this market. Apparently, opposing well-being effects related to atorvastatin is anticipated to confine the market growth and its graph. An expectation of driving the market and its growth has been noticed to lead, after the adoption of atorvastatin in the treatment of cardiovascular diseases.The projected onlookers for the Global Atorvastatin API Market are likely Contract Research Organizations, Atorvastatin API Manufacturers Atorvastatin API Manufacturers and Pharmaceutical Companies. Atorvastatin is mostly used to foil vital cardiovascular cases and lower entire and bad cholesterol (LDL-cholesterol) and triglyceride levels in the blood. It also does belong to the group of medicines known as statins, which is also known as the HMG-CoA reductase inhibitors. HMG-CoA reductase is an enzyme when elaborated is used in maintaining the cholesterol levels in the body.

Market segmentation

The segmentation for Global Atorvastatin API Market is given by Application wherein Hypercholesterolemia, Hypertriglyceridemia, Dyslipidemia Others are included. By the end of the year 2023, the hypercholesterolemia segment is likely to prime the market and record a considerable CAGR to reach USD 2,10,753.23 thousand. The players functioning in the Global Atorvastatin API Market are concentrating on mounting their global presence by entering untouched markets along with some product launches and decisions likely. Instead it is expected that a tall occurrence of hypercholesterolemia is expected to shoot up the market growth. Also, this slice is likely to exhibit the highest CAGR of 4.09% from 2018 to 2023.

Regional analysis

Geographically, the global optical sensing market is segmented and targeted into global regions like North America, Asia- Pacific, Middle East and Africa, Latin America and the Chinese market. Typically, by Region the market is segmented into US, Canada, Latin America. The European region is also covered right from Germany, UK, France, Sapin, Italy, Eastern Europe and the Rest of Europe. The Asian Pacific range covers the countries like China, India, Japan and the rest of Asia Pacific. It also covers Middle East and Africa.

Major players

Centrient Pharmaceuticals (The Netherlands), Cadila Pharmaceuticals (India), Sun Pharmaceutical Industries Ltd (India), Ind-Swift Labs Ltd (India), Zhejiang Hisun Pharmaceutical Co Ltd (China), Anuh Pharma Ltd (India), Jubilant Life Sciences Ltd (India), Morepen Laboratories Ltd (India), Dr. Reddy's Laboratories Ltd (India), Teva Pharmaceutical Industries Ltd (Israel), etc. are some of the major players in the Global Atorvastatin API Market

Table of Contents

1 Executive Summary

  • 1.1 Market Attractiveness Analysis
    • 1.1.1 Global Atorvastatin API Market, By Application
    • 1.1.2 Global Atorvastatin API Market, By Region

2 Market Introduction

  • 2.1 Definition
  • 2.2 Scope of the Study
  • 2.3 Market Structure

3 Research Methodology

  • 3.1 Research Process
  • 3.2 Primary Research
  • 3.3 Secondary Research
  • 3.4 Market Size Estimation
  • 3.5 Forecast Model
  • 3.6 List of Assumptions

4 Market Dynamics

  • 4.1 Introduction
  • 4.2 Drivers
    • 4.2.1 High Adoption of Atorvastatin in the Treatment of Cardiovascular Diseases
    • 4.2.2 Drivers Impact Analysis
  • 4.3 Restraints
    • 4.3.1 Adverse Health Effects Associated with Atorvastatin
    • 4.3.2 Restraints Impact Analysis
  • 4.4 Opportunities
    • 4.4.1 Growing Prevalence of Dyslipidemia in China

5 Market Factor Analysis

  • 5.1 Value Chain Analysis
    • 5.1.1 Research and Development
    • 5.1.2 Manufacturing
    • 5.1.3 Distribution & Sale
    • 5.1.4 Post-Sale Monitoring

  • 5.2 Porter's Five Forces Model
    • 5.2.1 Threat of New Entrants
    • 5.2.2 Intensity of Rivalry
    • 5.2.3 Threat of Substitutes
    • 5.2.4 Bargaining Power of Suppliers
    • 5.2.5 Bargaining Power of Buyers
  • 5.3 Regulatory Scenario
  • 5.4 Pipeline Analysis
    • 5.4.1 Introduction
    • 5.4.2 Atorvastatin Calcium Tablets, 40 mg
    • 5.4.3 Atorvastatin calcium 10 mg
    • 5.4.4 Atorvastatin
  • 5.5 Pricing Evolution

6 Global Atorvastatin API Market, by Application

  • 6.1 Introduction
  • 6.2 Hypercholesterolemia
  • 6.3 Hypertriglyceridemia
  • 6.4 Dyslipidemia
  • 6.5 Others

7 Global Atorvastatin API Market, by Region

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Latin America
  • 7.4 Europe
    • 7.4.1 France
    • 7.4.2 UK
    • 7.4.3 Spain
    • 7.4.4 Germany
    • 7.4.5 Italy
    • 7.4.6 Eastern Europe
    • 7.4.7 Rest of Europe

  • 7.5 Asia-Pacific
    • 7.5.1 China
    • 7.5.2 India
    • 7.5.3 Japan
    • 7.5.4 Rest of Asia-Pacific
  • 7.6 The Middle East and Africa
    • 7.6.1 Middle East
    • 7.6.2 Africa

8 Competitive Landscape

  • 8.1 Competitive Landscape
    • 8.1.1 Introduction

9 Company Profiles

  • 9.1 Teva Pharmaceutical Industries Ltd
    • 9.1.1 Company Overview
    • 9.1.2 Financial Overview
    • 9.1.3 Products Offered
    • 9.1.4 Key Developments
    • 9.1.5 SWOT Analysis
    • 9.1.6 Key Strategies
  • 9.2 Jubilant Life Sciences Ltd
    • 9.2.1 Company Overview
    • 9.2.2 Financial Overview
    • 9.2.3 Products Offered
    • 9.2.4 Key Developments
    • 9.2.5 SWOT Analysis
    • 9.2.6 Key Strategies
  • 9.3 Dr. Reddy's Laboratories Ltd
    • 9.3.1 Company Overview
    • 9.3.2 Financial Overview
    • 9.3.3 Products Offered
    • 9.3.4 Key Developments
    • 9.3.5 SWOT Analysis
    • 9.3.6 Key Strategies

  • 9.4 Sun Pharmaceutical Industries Ltd
    • 9.4.1 Company Overview
    • 9.4.2 Financial Overview
    • 9.4.3 Products Offered
    • 9.4.4 Key Developments
    • 9.4.5 SWOT Analysis
    • 9.4.6 Key Strategies
  • 9.5 Ind-Swift Labs Ltd
    • 9.5.1 Company Overview
    • 9.5.2 Financial Overview
    • 9.5.3 Products Offered
    • 9.5.4 Key Developments
    • 9.5.5 SWOT Analysis
    • 9.5.6 Key Strategies
  • 9.6 Morepen Laboratories Ltd
    • 9.6.1 Company Overview
    • 9.6.2 Financial Overview
    • 9.6.3 Products Offered
    • 9.6.4 Key Developments
    • 9.6.5 SWOT Analysis
    • 9.6.6 Key Strategies
  • 9.7 Zhejiang Hisun Pharmaceutical Co Ltd
    • 9.7.1 Company Overview
    • 9.7.2 Financial Overview
    • 9.7.3 Products Offered
    • 9.7.4 Key Developments
    • 9.7.5 SWOT Analysis
    • 9.7.6 Key Strategies
  • 9.8 Anuh Pharma Ltd
    • 9.8.1 Company Overview
    • 9.8.2 Financial Overview
    • 9.8.3 Products Offered
    • 9.8.4 Key Developments
    • 9.8.5 SWOT Analysis
    • 9.8.6 Key Strategies
  • 9.9 Centrient Pharmaceuticals
    • 9.9.1 Company Overview
    • 9.9.2 Financial Overview
    • 9.9.3 Products Offered
    • 9.9.4 Key Developments
    • 9.9.5 SWOT Analysis
    • 9.9.6 Key Strategies
  • 9.1 Cadila Pharmaceuticals
    • 9.10.1 Company Overview
    • 9.10.2 Financial Overview
    • 9.10.3 Products Offered
    • 9.10.4 Key Developments
    • 9.10.5 SWOT Analysis
    • 9.10.6 Key Strategies

10 Conclusion

List of Tables

  • TABLE 1 LIST OF ASSUMPTIONS
  • TABLE 2 ATORVASTATIN API MARKET: PIPELINE ANALYSIS
  • TABLE 3 PRICING EVOLUTION (2016-2018), BY REGION (USD PER KG)
  • TABLE 4 GLOBAL ATORVASTATIN API, BY APPLICATION, 2016-2023 (USD THOUSAND)
  • TABLE 5 GLOBAL ATORVASTATIN API MARKET, BY APPLICATION, 2016-2023 (METRIC TONS)
  • TABLE 6 GLOBAL ATORVASTATIN API MARKET FOR HYPERCHOLESTEROLEMIA, BY REGION, 2016-2023 (USD THOUSAND)
  • TABLE 7 GLOBAL ATORVASTATIN API MARKET FOR HYPERCHOLESTEROLEMIA, BY REGION, 2016-2023 (METRIC TONS)
  • TABLE 8 GLOBAL ATORVASTATIN APIMARKET FOR HYPERTRIGLYCERIDEMIA, BY REGION, 2016-2023 (USD THOUSAND)
  • TABLE 9 GLOBAL ATORVASTATIN API MARKET FOR HYPERTRIGLYCERIDEMIA, BY REGION, 2016-2023 (METRIC TONS)
  • TABLE 10 GLOBAL ATORVASTATIN API MARKET FOR DYSLIPIDEMIA, BY REGION, 2016-2023 (USD THOUSAND)
  • TABLE 11 GLOBAL ATORVASTATIN APIMARKET FOR DYSLIPIDEMIA, BY REGION, 2016-2023 (METRIC TONS)
  • TABLE 12 GLOBAL ATORVASTATIN API MARKET FOR OTHERS, BY REGION, 2016-2023 (USD THOUSAND)
  • TABLE 13 GLOBAL ATORVASTATIN API MARKET FOR OTHERS, BY REGION, 2016-2023 (METRIC TONS)
  • TABLE 14 GLOBAL ATORVASTATIN API MARKET, BY REGION, 2016-2023 (USD THOUSAND)
  • TABLE 15 GLOBAL ATORVASTATIN API MARKET, BY REGION, 2016-2023 (METRIC TONS)
  • TABLE 16 GLOBAL ATORVASTATIN API MARKET, BY APPLICATION, 2016-2023 (USD THOUSAND)
  • TABLE 17 GLOBAL ATORVASTATIN API MARKET, BY APPLICATION, 2016-2023 (METRIC TONS)
  • TABLE 18 NORTH AMERICA ATORVASTATIN API MARKET, BY COUNTRY, 2016-2023 (USD THOUSAND)
  • TABLE 19 NORTH AMERICA ATORVASTATIN APIMARKET, BY COUNTRY, 2016-2023 (METRIC TONS)
  • TABLE 20 NORTH AMERICA ATORVASTATIN API MARKET, BY APPLICATION, 2016-2023 (USD THOUSAND)
  • TABLE 21 NORTH AMERICA ATORVASTATIN API MARKET, BY APPLICATION, 2016-2023 (METRIC TONS)
  • TABLE 22 U.S. ATORVASTATIN API MARKET, BY APPLICATION, 2016-2023 (USD THOUSAND)
  • TABLE 23 U.S. ATORVASTATIN APIMARKET, BY APPLICATION, 2016-2023 (METRIC TONS)
  • TABLE 24 CANADA ATORVASTATIN APIMARKET, BY APPLICATION, 2016-2023 (USD THOUSAND)
  • TABLE 25 CANADA ATORVASTATIN APIMARKET, BY APPLICATION, 2016-2023 (METRIC TONS)
  • TABLE 26 LATIN AMERICA ATORVASTATIN API MARKET, BY APPLICATION, 2016-2023 (USD THOUSAND)
  • TABLE 27 LATIN AMERICA ATORVASTATIN API MARKET, BY APPLICATION, 2016-2023 (METRIC TONS)
  • TABLE 28 EUROPE ATORVASTATIN API MARKET, BY COUNTRY, 2016-2023 (USD THOUSAND)
  • TABLE 29 EUROPE ATORVASTATIN API MARKET, BY COUNTRY, 2016-2023 (METRIC TONS)
  • TABLE 30 EUROPE ATORVASTATIN API MARKET, BY APPLICATION, 2016-2023 (USD THOUSAND)
  • TABLE 31 EUROPE ATORVASTATIN API MARKET, BY APPLICATION, 2016-2023 (METRIC TONS)
  • TABLE 32 FRANCE ATORVASTATIN API MARKET, BY APPLICATION, 2016-2023 (USD THOUSAND)
  • TABLE 33 FRANCE ATORVASTATIN API MARKET, BY APPLICATION, 2016-2023 (METRIC TONS)
  • TABLE 34 UK ATORVASTATIN APIMARKET, BY APPLICATION, 2016-2023 (USD THOUSAND)
  • TABLE 35 UK ATORVASTATIN APIMARKET, BY APPLICATION, 2016-2023 (METRIC TONS)
  • TABLE 36 SPAIN ATORVASTATIN API MARKET, BY APPLICATION, 2016-2023 (USD THOUSAND)
  • TABLE 37 SPAIN ATORVASTATIN API MARKET, BY APPLICATION, 2016-2023 (METRIC TONS)
  • TABLE 38 GERMANY ATORVASTATIN API MARKET, BY APPLICATION, 2016-2023 (USD THOUSAND)
  • TABLE 39 GERMANY ATORVASTATIN API MARKET, BY APPLICATION, 2016-2023 (METRIC TONS)
  • TABLE 40 ITALY ATORVASTATIN API MARKET, BY APPLICATION, 2016-2023 (USD THOUSAND)
  • TABLE 41 ITALY ATORVASTATIN API MARKET, BY APPLICATION, 2016-2023 (METRIC TONS)
  • TABLE 42 EASTERN EUROPE ATORVASTATIN API MARKET, BY APPLICATION, 2016-2023 (USD THOUSAND)
  • TABLE 43 EASTERN EUROPE ATORVASTATIN API MARKET, BY APPLICATION, 2016-2023 (METRIC TONS)
  • TABLE 44 REST OF EUROPE ATORVASTATIN API MARKET, BY APPLICATION, 2016-2023 (USD THOUSAND)
  • TABLE 45 REST OF EUROPE ATORVASTATIN API MARKET, BY APPLICATION, 2016-2023 (METRIC TONS)
  • TABLE 46 ASIA-PACIFIC ATORVASTATIN API MARKET, BY COUNTRY, 2016-2023 (USD THOUSAND)
  • TABLE 47 ASIA-PACIFIC ATORVASTATIN API MARKET, BY COUNTRY, 2016-2023 (METRIC TONS)
  • TABLE 48 ASIA-PACIFIC ATORVASTATIN API MARKET, BY APPLICATION, 2016-2023 (USD THOUSAND)
  • TABLE 49 ASIA-PACIFIC ATORVASTATIN API MARKET, BY APPLICATION, 2016-2023 (METRIC TONS)
  • TABLE 50 CHINA ATORVASTATIN API MARKET, BY APPLICATION, 2016-2023 (USD THOUSAND)
  • TABLE 51 CHINA ATORVASTATIN APIMARKET, BY APPLICATION, 2016-2023 (METRIC TONS)
  • TABLE 52 INDIA ATORVASTATIN API MARKET, BY APPLICATION, 2016-2023 (USD THOUSAND)
  • TABLE 53 INDIA ATORVASTATIN API MARKET, BY APPLICATION, 2016-2023 (METRIC TONS)
  • TABLE 54 JAPAN ATORVASTATIN API MARKET, BY APPLICATION, 2016-2023 (USD THOUSAND)
  • TABLE 55 JAPAN ATORVASTATIN APIMARKET, BY APPLICATION, 2016-2023 (METRIC TONS)
  • TABLE 56 REST OF ASIA-PACIFIC ATORVASTATIN API MARKET, BY APPLICATION, 2016-2023 (USD THOUSAND)
  • TABLE 57 REST OF ASIA-PACIFIC ATORVASTATIN API MARKET, BY APPLICATION, 2016-2023 (METRIC TONS)
  • TABLE 58 THE MIDDLE EAST AND AFRICA ATORVASTATIN API MARKET, BY REGION, 2016-2023 (USD THOUSAND)
  • TABLE 59 THE MIDDLE EAST AND AFRICA ATORVASTATIN API MARKET, BY REGION, 2016-2023 (METRIC TONS)
  • TABLE 60 THE MIDDLE EAST AND AFRICA ATORVASTATIN API MARKET, BY APPLICATION, 2016-2023 (USD THOUSAND)
  • TABLE 61 THE MIDDLE EAST AND AFRICA ATORVASTATIN APIMARKET, BY APPLICATION, 2016-2023 (METRIC TONS)
  • TABLE 62 MIDDLE EAST ATORVASTATIN API MARKET, BY APPLICATION, 2016-2023 (USD THOUSAND)
  • TABLE 63 MIDDLE EAST ATORVASTATIN API MARKET, BY APPLICATION, 2016-2023 (METRIC TONS)
  • TABLE 64 AFRICA ATORVASTATIN APIMARKET, BY APPLICATION, 2016-2023 (USD THOUSAND)
  • TABLE 65 AFRICA ATORVASTATIN APIMARKET, BY APPLICATION, 2016-2023 (METRIC TONS)

List of Figures

  • FIGURE 1 MARKET SYNOPSIS
  • FIGURE 2 MARKET ATTRACTIVENESS ANALYSIS: GLOBAL ATORVASTATIN API MARKET
  • FIGURE 3 GLOBAL ATORVASTATIN API MARKET ANALYSIS, BY APPLICATION
  • FIGURE 4 GLOBAL ATORVASTATIN API MARKET ANALYSIS BY REGION
  • FIGURE 5 GLOBAL ATORVASTATIN API MARKET: MARKET STRUCTURE
  • FIGURE 6 RESEARCH PROCESS OF MRFR
  • FIGURE 7 TOP-DOWN & BOTTOM-UP APPROACH
  • FIGURE 8 MARKET DYNAMICS OVERVIEW
  • FIGURE 9 DRIVERS IMPACT ANALYSIS
  • FIGURE 10 RESTRAINTS IMPACT ANALYSIS
  • FIGURE 11 SUPPLY CHAIN: GLOBAL ATORVASTATIN API MARKET
  • FIGURE 12 PORTER'S FIVE FORCES ANALYSIS OF THE GLOBAL ATORVASTATIN API MARKET
  • FIGURE 13 GLOBAL ATORVASTATIN API MARKET, BY APPLICATION, 2017 (SHARE %)
  • FIGURE 14 GLOBAL ATORVASTATIN API MARKET, BY APPLICATION, 2016-2023 (USD THOUSAND)
  • FIGURE 15 GLOBAL ATORVASTATIN API MARKET BY REGION, 2016-2023 (USD THOUSAND)
Back to Top